Page last updated: 2024-08-18

pyrroles and incb-018424

pyrroles has been researched along with incb-018424 in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	33 (86.84)	24.3611
2020's	5 (13.16)	2.80

Authors

Authors	Studies
Dabade, TS; Feldman, SR; Gustafson, CJ; Kwatra, SG	1
Chan, C; Ivashkiv, LB; Xu, K; Yarilina, A	1
Heinzl, S	1
Gadina, M; Ghoreschi, K	1
Aittomäki, S; Pesu, M	1
Gadina, M	1
Bosque, A; Detorio, M; Gavegnano, C; Montero, C; Planelles, V; Schinazi, RF	1
Han, G	1
Armstrong, AW; Hsu, L	1
Bujak, A; Dymek, B; Dzwonek, K; Grygielewicz, P; Gunerka, P; Lamparska-Przybysz, M; Pietrucha, T; Stanczak, A; Turowski, P; Wieczorek, M	1
Choi, J; King, B; Lee, AI	1
Ahmad Nasrollahi, S; Firooz, A; Hashemi, A; Nassiri Kashani, M; Samadi, A	1
Damsky, W; King, BA	1
Ramot, Y; Shreberk-Hassidim, R; Zlotogorski, A	1
Han, Y; Mesplède, T; Quan, Y; Wainberg, MA; Xu, H	1
Bamford, RN; Chen, J; Del Mistro, A; Epstein, AL; Jaffe, ES; Kadin, ME; Nakagawa, M; Nicolae, A; Ouyang, ST; Petrus, MN; Pittaluga, S; Raffeld, M; Waldmann, TA; Woessner, R; Xiao, W; Zhang, Y	1
Bayart, CB; Brichta, L; Craiglow, BG; DeNiro, KL; Sidbury, R	1
Ceric-Dehdari, P; Meurer, M	1
Cardwell, LA; Cline, A; Feldman, SR	1
Brehm, JH; Cameron, C; Dupuy, FP; Gavegnano, C; Hurwitz, SJ; Kulpa, DA; Marconi, VC; Ribeiro, SP; Routy, JP; Sabbagh, L; Santos, S; Schinazi, RF; Sékaly, RP; Talla, A	1
Bitterman, A; Borbon, J; Cerise, J; Chen, JC; Christiano, AM; Clynes, R; Jabbari, A; Mackay-Wiggan, J; Sansaricq, F; Ulerio, G	1
Bonnel, D; Eriksson, AH; Legouffe, R; Mortensen, RW; Nielsen, KT; Pamelard, F; Stauber, J	1
Abinun, M; Allenspach, EJ; Castro-Wagner, J; Cooper, MA; Cunningham-Rundles, C; Demirdag, YY; Eckstein, O; Forbes, LR; Freeman, AF; Gennery, A; Guillerman, RP; Holland, SM; Leiding, JW; Lilic, D; Milner, JD; Olbrich, P; Patel, NC; Plant, AS; Schussler, E; Slatter, M; Su, HC; Szabolcs, P; Torgerson, TR; Vogel, TP; Weinacht, KG; Zerbe, C	1
Bokhari, L; Sinclair, R	1
King, BA; Liu, LY	1
Finlay, JL; Li, C; Lin, J; Ma, L; Pierson, CR; Wei, J	1
Abudu, M; Gordon, SC; Ko, JM; Rosmarin, D; Zancanaro, P	1
Almutairi, N; Hussain, NH; Nour, TM	1
Santos, LDN; Shapiro, J	1
Dina, Y; McKesey, J; Pandya, AG	1
Gomez-Arteaga, A; Horwitz, S; Inghirami, G; Margolskee, E; van Besien, K; Wei, MT	1
Aguilar-Luque, M; Gay-Mimbrera, J; Gómez-Arias, PJ; Gómez-García, F; Hernandez, J; Isla-Tejera, B; Montilla, AM; Ruano, J; Velez García-Nieto, A; Viguera-Guerra, I	1
Kwon, O; Park, H; Yu, DA	1
Georgiou, S; Plachouri, KM	1
Damsky, W; King, B; Peterson, D	1
Ballerie, A; Batteux, F; Fardel, O; Jego, P; Jeljeli, M; Jouneau, S; Lecureur, V; Lelong, M; Lescoat, A; Morzadec, C; Piquet-Pellorce, C; Vernhet, L	1
Gong, Y; Qi, F; Zhang, J; Zhou, S; Zhu, B	1
Chang, Y; Chen, J; Christiano, AM; Dai, Z	1

Reviews

17 review(s) available for pyrroles and incb-018424

Article	Year
JAK inhibitors in psoriasis: a promising new treatment modality. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:8 Topics: Animals; Cytokines; Humans; Janus Kinases; Nitriles; Piperidines; Psoriasis; Pyrazoles; Pyrimidines; Pyrroles; Severity of Illness Index	2012
[Janus kinase inhibitors as a new therapeutic principle]. Medizinische Monatsschrift fur Pharmazeuten, 2012, Volume: 35, Issue:10 Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Enzyme Inhibitors; Humans; Janus Kinases; Nitriles; Piperidines; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction	2012
Jakpot! New small molecules in autoimmune and inflammatory diseases. Experimental dermatology, 2014, Volume: 23, Issue:1 Topics: Animals; Autoimmune Diseases; Cytokines; Humans; Immunosuppressive Agents; Inflammation; Janus Kinases; Mice; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction	2014
Therapeutic targeting of the Jak/STAT pathway. Basic & clinical pharmacology & toxicology, 2014, Volume: 114, Issue:1 Topics: Animals; Autoimmune Diseases; Cytokines; Disease Models, Animal; Humans; Janus Kinases; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; STAT Transcription Factors	2014
Janus kinases: an ideal target for the treatment of autoimmune diseases. The journal of investigative dermatology. Symposium proceedings, 2013, Volume: 16, Issue:1 Topics: Animals; Autoimmune Diseases; Cytokines; Humans; Janus Kinases; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; STAT Transcription Factors	2013
In the pipeline for psoriasis: upcoming psoriasis treatments. Cutis, 2014, Volume: 93, Issue:3 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Certolizumab Pegol; Etanercept; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin-12 Subunit p40; Janus Kinases; Nitriles; Piperidines; Polyethylene Glycols; Protein Kinase Inhibitors; Psoriasis; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Interleukin-17; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha; Ustekinumab	2014
JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. Journal of immunology research, 2014, Volume: 2014 Topics: Clinical Trials as Topic; Gene Expression Regulation; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Treatment Outcome	2014
Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature. The Journal of dermatological treatment, 2017, Volume: 28, Issue:6 Topics: Alopecia Areata; Azetidines; Dermatitis, Atopic; Humans; Janus Kinase Inhibitors; Janus Kinases; Nitriles; Piperidines; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases; Sulfonamides; Vitiligo	2017
JAK inhibitors in dermatology: The promise of a new drug class. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4 Topics: Alopecia Areata; Anti-Inflammatory Agents; Azetidines; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Skin Diseases; Sulfonamides; Vitiligo	2017
Janus kinase inhibitors in dermatology: A systematic review. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4 Topics: Alopecia Areata; Anti-Inflammatory Agents; Antineoplastic Agents; Azetidines; Dermatologic Agents; Drug Eruptions; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Signal Transduction; Skin Diseases; Sulfonamides	2017
[Systemic treatment of vitiligo : Balance and current developments]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017, Volume: 68, Issue:11 Topics: alpha-MSH; Animals; Biomarkers; Combined Modality Therapy; Disease Models, Animal; Humans; Immunosuppressive Agents; Interferon-alpha; Janus Kinases; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Ultraviolet Therapy; Vitiligo	2017
Advances in treating psoriasis in the elderly with small molecule inhibitors. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:18 Topics: Adamantane; Azetidines; Clinical Trials as Topic; Humans; Niacinamide; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Severity of Illness Index; Small Molecule Libraries; Sulfonamides; Thalidomide	2017
What's New in Hair Loss. Dermatologic clinics, 2019, Volume: 37, Issue:2 Topics: 5-alpha Reductase Inhibitors; Alopecia; Alopecia Areata; Azetidines; Humans; Janus Kinase Inhibitors; Nitriles; Piperidines; Platelet-Rich Plasma; Purines; Pyrazoles; Pyrimidines; Pyrroles; Retinoids; Sulfonamides	2019
Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review. BMJ open, 2019, 05-22, Volume: 9, Issue:5 Topics: Humans; Janus Kinase Inhibitors; Janus Kinases; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases; STAT Transcription Factors	2019
Janus kinase inhibitors: An innovative treatment for alopecia areata. The Journal of dermatology, 2019, Volume: 46, Issue:8 Topics: Administration, Oral; Alopecia Areata; Azetidines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Janus Kinases; Middle Aged; Nitriles; Piperidines; Purines; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Sulfonamides; T-Lymphocytes, Cytotoxic; Treatment Outcome	2019
JAK inhibitors in chronic plaque psoriasis: What is known so far. Drugs of today (Barcelona, Spain : 1998), 2020, Volume: 56, Issue:2 Topics: Adamantane; Azetidines; Humans; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Nitriles; Piperidines; Prospective Studies; Psoriasis; Purines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sulfonamides; Triazoles	2020
Biological Therapies for Atopic Dermatitis: A Systematic Review. Dermatology (Basel, Switzerland), 2021, Volume: 237, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; Biological Products; Carbamates; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Heterocyclic Compounds, 3-Ring; Humans; Nitriles; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Sulfonamides	2021

Trials

3 trial(s) available for pyrroles and incb-018424

Article	Year
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis. The Journal of investigative dermatology, 2018, Volume: 138, Issue:7 Topics: Adult; Alopecia Areata; Autoimmune Diseases; Biopsy; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Hair Follicle; Humans; Janus Kinase Inhibitors; Janus Kinases; Male; Middle Aged; Nitriles; Photography; Pilot Projects; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Severity of Illness Index; Treatment Outcome; Young Adult	2018
Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study. International journal of dermatology, 2018, Volume: 57, Issue:12 Topics: Administration, Cutaneous; Alopecia; Clobetasol; Double-Blind Method; Glucocorticoids; Hair; Humans; Janus Kinase Inhibitors; Nitriles; Ointments; Pilot Projects; Piperidines; Prospective Studies; Pyrazoles; Pyrimidines; Pyrroles	2018
Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study. Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Hair; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Time Factors; Young Adult	2019

Other Studies

18 other study(ies) available for pyrroles and incb-018424

Article	Year
Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis and rheumatism, 2012, Volume: 64, Issue:12 Topics: Animals; Arthritis, Rheumatoid; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Humans; In Vitro Techniques; Inflammation; Interleukin-6; Janus Kinases; Macrophages; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Nitriles; Piperidines; Proto-Oncogene Proteins c-jun; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; STAT1 Transcription Factor; Synovial Membrane; Tumor Necrosis Factor-alpha	2012
Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4 Topics: Animals; Cells, Cultured; HIV Infections; HIV-1; Humans; Janus Kinase 1; Janus Kinase 2; Lymphocytes; Macaca mulatta; Macrophages; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Virus Replication	2014
Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors. European journal of pharmacology, 2015, Oct-15, Volume: 765 Topics: bcl-X Protein; Cell Cycle; Cell Line, Tumor; Cyclin D1; Down-Regulation; Gene Expression; Humans; Imidazoles; Janus Kinases; Leukemia, Myeloid, Acute; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridazines; Pyrimidines; Pyrroles; Pyrrolidines; Sulfonamides	2015
Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. The Journal of investigative dermatology, 2017, Volume: 137, Issue:4 Topics: Adult; Aged; Female; Humans; Hypereosinophilic Syndrome; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases	2017
JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1. Journal of virology, 2017, 05-01, Volume: 91, Issue:9 Topics: Binding Sites; CD4 Antigens; CD4-Positive T-Lymphocytes; env Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Interleukin-2; Janus Kinases; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Pyrrolidines; Signal Transduction; STAT Transcription Factors; Sulfonamides; Tetradecanoylphorbol Acetate; TOR Serine-Threonine Kinases; Virus Internalization; Virus Replication	2017
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proceedings of the National Academy of Sciences of the United States of America, 2017, 04-11, Volume: 114, Issue:15 Topics: Anaplastic Lymphoma Kinase; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokine Receptor gp130; Cytokines; Humans; Janus Kinase 1; Lymphoma, Large-Cell, Anaplastic; Mice; Nitriles; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Cytokine; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2017
Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata. Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:1 Topics: Administration, Cutaneous; Adolescent; Alopecia Areata; Child, Preschool; Female; Humans; Janus Kinases; Male; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Skin Cream	2017
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors. PLoS pathogens, 2017, Volume: 13, Issue:12 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; HIV Infections; HIV-1; Humans; Janus Kinase Inhibitors; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Virus Latency; Virus Replication	2017
MALDI imaging facilitates new topical drug development process by determining quantitative skin distribution profiles. Analytical and bioanalytical chemistry, 2018, Volume: 410, Issue:11 Topics: Acetamides; Administration, Topical; Aminopyridines; Benzamides; Cyclopropanes; Drug Discovery; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Skin; Skin Absorption; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2018
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. The Journal of allergy and clinical immunology, 2018, Volume: 142, Issue:5 Topics: Adolescent; Adult; Child; Female; Gain of Function Mutation; Humans; Immunologic Deficiency Syndromes; Janus Kinases; Male; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; STAT1 Transcription Factor; STAT3 Transcription Factor; Treatment Outcome	2018
Ruxolitinib for the treatment of severe alopecia areata. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:2 Topics: Adolescent; Adult; Alopecia Areata; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hair; Humans; Male; Middle Aged; Nitriles; Patient Satisfaction; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Retrospective Studies; Sampling Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2019
Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. Current cancer drug targets, 2019, Volume: 19, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Movement; Cell Proliferation; Cerebellar Neoplasms; Cisplatin; Dasatinib; Drug Synergism; Humans; Medulloblastoma; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; src-Family Kinases; STAT3 Transcription Factor; Tumor Cells, Cultured	2019
Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:4 Topics: Adult; Alopecia Areata; Female; Humans; Janus Kinases; Middle Aged; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Recurrence; Withholding Treatment	2019
Disorders of Hypopigmentation Journal of drugs in dermatology : JDD, 2019, Mar-01, Volume: 18, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Autoimmune Diseases; CD8-Positive T-Lymphocytes; Counseling; Dermatologic Agents; Diagnosis, Differential; Epidermis; Humans; Janus Kinases; Melanocytes; Mycosis Fungoides; Nitriles; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Quality of Life; Skin Pigmentation; Tinea Versicolor; Vitiligo	2019
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation. Leukemia & lymphoma, 2019, Volume: 60, Issue:7 Topics: Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Mutation; Nitriles; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles	2019
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:6 Topics: Arthritis, Rheumatoid; Azetidines; Betacoronavirus; Colitis, Ulcerative; Coronavirus Infections; COVID-19; Cytokines; Dermatitis, Atopic; Heterocyclic Compounds, 3-Ring; Humans; Immunomodulation; Janus Kinases; Nitriles; Pandemics; Piperidines; Pneumonia, Viral; Primary Myelofibrosis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; SARS-CoV-2; STAT Transcription Factors; Sulfonamides	2020
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease. Biochemical pharmacology, 2020, Volume: 178 Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Chemokine CXCL13; Female; Gene Expression Regulation; Hypochlorous Acid; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Lung; Lung Diseases, Interstitial; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Nitriles; Piperidines; Primary Cell Culture; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Immunologic; Scleroderma, Systemic; Suppressor of Cytokine Signaling 3 Protein	2020
Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata. JCI insight, 2021, 04-08, Volume: 6, Issue:7 Topics: Administration, Topical; Alopecia Areata; Animals; Azetidines; CD8-Positive T-Lymphocytes; Cytokines; Isonicotinic Acids; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Macrophages; Mice, Inbred C3H; Nitriles; NK Cell Lectin-Like Receptor Subfamily K; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Triazoles	2021